A B S T R A C T Properties of adenyl cyclase of normal adrenals and of a corticosterone-producing adrenal cancer of the rat have been compared. Enzyme activity was found in all particulate fractions of both tissues. The cyclase of the tumor as well as of the adrenals was stimulated by adrenocorticotropic hormone (ACTH) over similar concentration ranges. Unexpectedly, the tumor enzyme was also stimulated by epinephrine, norepinephrine, and thyroid-stimulating hormone (TSH). These hormones produced a dose-related effect over a concentration span that was comparable with that for ACTH. The tumor cyclase was not responsive to angiotensin II, vasopressin, glucagon, insulin, growth hormone, parathyroid hormone, and thyrocalcitonin. ACTH was the only hormonal preparation that stimulated normal adrenal cyclase. These findings are compatible either with the possibility that the adenyl cyclase receptor of the tumor has undergone structural alteration with a consequent loss of specificity for ACTH or with the possibility that the tumor possesses several cyclase regulatory receptors.
INTRODUCTION
Adrenocortical neoplasms that produce glucocorticoids or 17-ketosteroids (or both) are active in hormone production in the absence of adrenocorticotropic hormone (ACTH),1 contrasting with the ACTH dependence of the normal adrenal cortex. Also, in contrast with the normal adrenals, the growth of the tumors is not dependent on the presence of ACTH. In the normal adrenal, ACTH stimulates the activity of adenyl cyclase, leading to increased conversion of adenosinetriphosphate (ATP) to cyclic adenosine 3',5'-monophosphate (cyclic AMP) Received for publication 7 December 1970. 1 Abbreviations used in this paper: ACTH, adrenocorticotropic hormone; cyclic AMP, cyclic adenosine 3',5'-monophosphate; FSH, follicle-stimulating hormone; LH, luteinizing hormone; TSH, thyroid-stimulating hormone. 2Schorr, I.. and R. L. Ney. Unpublished observations.
(1, 2). The cyclic nucleotide in turn brings about an accelerated rate of steroidogenesis (2, 3) . These considerations have led us to examine the properties of adenyl cyclase in an adrenocortical carcinoma. As a readily and continuously available supply of tumor tissue, we have employed a corticosterone-producing transplantable rat adrenocortical carcinoma (4, 5) . Previous studies have revealed that the tumor possesses adenyl cyclase activity capable of stimulation by ACTH (5). The studies described here have examined the subcellular distribution of adenyl cyclase in the tumor and have examined possible regulatory influences on the tumor enzyme. Unexpectedly, the tumor adenyl cyclase has been found to be responsive not only to ACTH, but also to certain other hormones as well.
METHODS
The tumor employed in these studies was rat adrenocortical carcinoma 494 originally found by Snell and Stewart (4) . The tumor was maintained by transplantation in male Sprague-Dawley rats as previously described (5) . Normal adrenals were obtained from male Sprague-Dawley rats weighing 160-180 g.
Tumor tissue and adrenals (50-400 mg/ml) were homogenized in a buffer containing 62.2 mm Tris (hydroxymethyl) aminomethane (HCl) and 15.5 mm theophylline at pH 7.4. Whole homogenates or fractions derived from them by centrifugation were used for adenyl cyclase assays. To obtain the fractions, the homogenate was centrifuged at 1000 g for 10 min. The sediment was collected and the supernatant centrifuged at 10,000 g for 10 min. This sediment was collected, and its supernatant was centrifuged at 105,000 g for 60 min. The sedimented particles were resuspended in the homogenizing medium, utilizing volumes adjusted to yield approximately equal protein concentrations in the different fractions in any given experiment. The tissue homogenates and centrifuged fractions were maintained at 4°C throughout these manipulations. Adenyl cyclase activity was determined by measuring the rate of conversion of a-ATP-"P to "P-labeled cyclic AMP. Cyclic AMP uniformly labeled with tritium was added to allow correction for cyclic AMP breakdown during the incubation and for losses during subsequent purification steps. Homogenates or particles suspended in a volume of 40 pi were added to the remainder of the components of the assay made up in a volume of 30 pl. The final concentrations of components in the assay mixture were 2 mm ATP, 3 mM MgSO4, 2 mm 3',5'-cyclic AMP, 40 mm Tris, and 10 mm theophylline. 8 mm phosphoenol pyruvate and 0.3 U of pyruvate kinase per incubate were included as an ATPgenerating system. Each assay tube contained a-ATP-3P in amounts of 1-2 ,Ci in different experiments as well as 0.05 ACi cyclic AMP-'H. The assays were carried out at pH 7.4 for 20 min in a water bath at 30'C with shaking. For each enzyme preparation assayed there was a blank. The blank was placed in a boiling water bath for 90 sec before the 20 min incubation, whereas the assay tube was boiled at the termination of the incubation. In all other respects the assay tube and its blank were handled in an identical manner.
After the termination of the incubation, the tubes were centrifuged at 27,000 g. The supernatant was chromatographed on silicic acid fiberglass sheets (Chromar 1000; Mallinckrodt Chemical Works, St. Louis, Mo.) in an ascending system composed of 0.03 M NH4Cl, acetone, isopropanol, and n-butanol (2: 2: 2: 3) for 75 min. In this system, cyclic AMP migrates close to the solvent front, ATP remains close to the origin, and AMP and ADP migrate at intermediate rates. The cyclic AMP area was eluted in 0.7 ml water, and 0.2 ml each of 0.25 M Ba(OH)2 and 0.25 M ZnSO4 was added. After centrifugation at 27,000 g, the supernatant was transferred to scintillation vials. To these was added 15 ml of scintillation fluid prepared by adding 2400 ml toluene and 1250 ml Triton X-100 to 100 ml Permafluor 25X (Packard Instrument Co., Inc., Downers Grove, Ill.). Specimens were counted 10 times for 10 min each time with about 27% efficiency for 'H and 80% for '3P in a Packard 3320 Tri-Carb liquid scintillation spectrometer. Only a 0.7% spillover of 3P counts into the 3H channel was observed, and there was no spillover of 3H counts into the 32P channel. The amount of cyclic AMP formed was corrected for losses on the basis of recovery of cyclic AMP-3H. The amount of cyclic AMP found in each blank was subtracted from the corresponding incubate. Adenyl cyclase activity is expressed as picomoles cyclic AMP formed per milligram protein per 20 minutes. The identity and purity of the isolated cyclic AMP were established by methods previously described by Dorrington and Baggett (6) .
Protein concentrations were determined by the method of Lowry, Rosebrough, Farr, and Randall (7). Statistical analysis employed the Student t test.
The ACTH preparation, containing an activity of 57 USP U/mg, was a gift of Parke, Davis & Co. (Detroit, Mich.). Thyroid-stimulating hormone (TSH) (NIH-S6 and NIH-B5), luteinizing hormone (LH) (NIH-S16 and NIH-B7), and follicle-stimulating hormone (FSH) (NIH-S8 and NIH-P1) were (Table II) . Activity was lowest in particles sedimenting at 105,000 g. Although a small amount of activity was detected in initial experiments employing 105,000 g supernatant fractions, this observation could not be reproducibly documented.
Responses of adrenal cancer and normal adrenal adenyl cyclase to ACTH and NaF. Each of the particulate fractions of the tumor and of the adrenals was stimulated by ACTH (Tables I and II ). The responses of the 105,000 g particles were small. Dose-response curves employing 1000 g particles from the tumor and from normal adrenals are shown in Fig. 1 . Responses of the tumor to any given concentration of ACTH were generally greater than responses of normal adrenals, an observation noted for each tissue fraction. The lowest stimulatory concentration of ACTH for both tissues was 0.051 U/ml.
NaF also stimulated adenyl cyclase activity in each particulate fraction of the tumor and of normal adrenals (Tables I and II) . However, the effects of NaF on the tumor were small, whereas NaF produced eightfold or more stimulation of the normal adrenal enzyme. This rather marked difference in the responses of the tumor and of the normal adrenal enzyme was noted for NaF concentrations ranging from 10 to 40 mmoles/liter. Responses of adrenal cancer adenyl cyclase to catecholamines. To further characterize the properties of the tumor cyclase, a wide variety of other hormones were tested for effects on enzyme activity. Unexpectedly, the tumor cyclase was stimulated by epinephrine and by norepinephrine. Results of experiments employing 1000 g particles are summarized in Table III , and dose-response curves for each of the hormones are shown in Fig. 2 . The lowest effective concentration for each of the hormones was 10' moles/liter. Normal adrenal adenyl cyclase was unresponsive to the catecholamines at concentrations as high as 10' moles/liter.
Response of adrenal cancer adenyl cyclase to TSH. The tumor cyclase was also stimulated by each preparation of TSH tested. Results of experiments with 1000 g particles are summarized in Table III , and a dose-response curve is shown in Fig. 3 . TSH was active at concentrations as low as 0.0036 USP U/ml. The possibility that these responses were due to contamination of TSH preparations by ACTH was excluded by the observation that even 1000-fold increases in the concentration of the TSH preparations (3.6 U/ml) failed to have any effect on normal adrenal adenyl cyclase activity.
Tests for additive effects of different hormones in stimulating adrenal cancer adenyl cyclase. Possible additive effects of ACTH, TSH, and epinephrine on tumor cyclase activity were looked for, employing high concentrations of each of the hormones. Table IV shows results of two such experiments with 1000 g tumor particles. No additive effects were observed.
Other hormones tested. Growth hormone, angiotensin II, vasopressin, insulin, parathyroid hormone, thyrocalcitonin, and glucagon failed to produce statistically significant stimulation of the adenyl cyclase of the adeno- (12) (7)
* Number of experiments. Each of the n (7) pooled results is the mean of an assay done in duplicate. t ACTH, 0.2 U/ml. § 40 mM NaF. Responses are on the vertical axis.
cortical cancer or of normal adrenals (Table V) . FSH preparations (NIH-S8 and NIH-P1) and LH preparations (NIH-S16 and NIH-B7) significantly stimulated the tumor cyclase (Tables II and V was excluded by their failure to affect normal adrenal adenyl cyclase activity at concentrations 100-to 1000-fold greater than those required to stimulate the tumor enzyme. The tumor enzyme was also stimulated by preparations of LH and FSH. However, these preparations contained TSH contamination at levels sufficient to have accounted for their stimulation of the tumor cyclase. Further studies with more highly purified preparations of LH and FSH will be needed to determine whether one or both of these hormones do in fact have any effect on the tumor enzyme. Tumor adenyl cyclase was unresponsive to a wide variety of other hormones (Table V) . ACTH was the only hormone preparation that stimulated normal adrenal adenyl cyclase. The results showing responses of tumor adenyl cyclase to TSH, epinephrine, and norepinephrine as well as to ACTH, suggest either that the receptor portion of the tumor adenyl cyclase has undergone structural alteration with consequent loss of hormonal specificity or that the tumor possesses additional "ectopic" adenyl cyclase receptors. The presence of ectopic adenyl cyclase receptors might be analogous to the synthesis of ectopic hormones by certain tumors (8) . In this case, however, the ectopic substances would be incorporated in the structure of the cell rather than being delivered into the circulation.
The physiological significance of the responses of the tumor cyclase to hormones other than ACTH remains to be ascertained. Concentrations of cyclic AMP in the tumor in vivo are about 4 nmoles/g, whereas concentrations in the nontumorous adrenals of the tumor-bearing animals are about 2 nmoles/g (5) . The administration of large doses of ACTH results in about a 50-fold increase in cyclic AMP levels in nontumorous adrenals, but tumor levels rise only to about 6 nmoles/g. Although the capacity of the tumor to increase cyclic AMP levels in vivo is limited compared with that of normal adrenals, concentrations of cyclic AMP in the range 4-6 nmoles/g in normal adrenals would be associated with a high rate of steroidogenesis (2) , whereas the tumor is comparatively inefficient as a steroidogenic tissue even at these cyclic AMP levels (5 
